便失禁:调查,治疗和管理
1Frailty Specialist Nurse, Sutton Health and Care, Epsom and St Helier NHS Trust.
British journal of community nursing
|November 5, 2024
概括
便失禁影响了许多成年人,特别是妇女和老年人. 早期识别和初级保健治疗可逆性原因可以显著改善结果.
科学领域:
- 胃肠病学 胃肠病学
- 老年病的医生 老年病的医生
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 便失禁 (FI) 是一种普遍但未被认可的疾病.
- 它不成比例地影响妇女和老年人口,患病率随着年龄的增长而增加.
- 发病率是由于多种因素的复杂相互作用而产生的,其中一些因素容易受到初级保健干预的影响.
研究的目的:
- 探索导致成人便失禁的病因因素.
- 概述在初级保健机构中识别和管理可逆原因的策略.
- 提供有关专业治疗和管理难治病例的指导.
主要方法:
- 文献综述和综合关于便失禁的当前证据.
- 讨论初级保健评估和管理途径.
- 关于先进治疗选择和息治疗的概述.
主要成果:
- 便失禁的可逆原因通常可以在初级保健中解决.
- 对评估的结构化方法对于有效的管理至关重要.
- 及时的初级保健干预可以在许多情况下避免需要专家转诊.
结论:
- 便失禁需要一个系统的诊断和治疗方法.
- 初级保健在管理可逆原因方面发挥着至关重要的作用.
- 有效的管理策略可以改善便失禁患者的生活质量.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
123
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
123
Irritable Bowel Syndrome III: Medical and Nursing Management
172
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
172
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
321
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
321
Drugs for Treatment of Constipation-Predominant IBS
137
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
137
Drugs for Treatment of Diarrhea-Predominant IBS
149
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
149
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
144
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
144


